Clinical Trial Update: Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

View source ↗

Summary

A completed clinical trial evaluated the effect of growth hormone on fibroblast growth factor 23 (FGF23) in individuals with growth disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Growth Disorders | Status: COMPLETED